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BY-NC-ND license (http://creativecomAbstract Carotid artery stenosis (CAS) is primarily caused by atherosclerotic plaque. Progres-
sive inflammation may contribute to the rupture of an atherosclerotic plaque. The platelet-to-
lymphocyte ratio (PLR) is a new and simple marker that indicates inflammation. In this study,
we aimed to investigate the use of the PLR to determine the severity of CAS. One hundred forty
patients were chosen from among patients who underwent carotid angiography in our institu-
tion. Symptomatic patients with stenosis >50% in the carotid arteries and asymptomatic pa-
tients with stenosis >80% were diagnosed via carotid angiography as having critical stenosis.
Patients were classified into two groups. Group 1 included patients who had critical CAS,
whereas Group 2 included patients with noncritical CAS, as determined by carotid angiography.
Correlations between the PLR and the severity of CAS were analyzed. There were no significant
differences in sex and age between the two groups. The PLR was 162.5  84.7 in the noncritical
CAS group patients and 94.9  60.3 in the critical CAS group patients (p < 0.0001). The PLR
value of 117.1 had 89% sensitivity and 68% specificity for CAS [95% confidence interval, 0.043
e0.159; area under the curve, 0.101  0.03)]. In this study, we have shown that PLR values
may be associated with critical stenosis in at least one of the carotid arteries. Furthermore,
PLR values may be used to predict critical stenosis in the carotid arteries.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).eclare no conflicts of interest.
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Carotid artery stenosis and the PLR 87IntroductionCarotid artery stenosis (CAS) is an important arterial
occlusive disease that may lead to the formation of cranial
ischemic infarction and stroke. Atherosclerosis has a role in
90% of the etiologies of all extracranial carotid artery dis-
eases [1e4]. Atherosclerosis is a systemic chronic inflam-
matory disease of the arterial intima. It affects overall
systemic arterial circulation [3]. Increased inflammatory
status is related to a poor prognosis for atherosclerosis [4].
Increased platelet activation has an important role in the
initiation and progression of atherosclerosis [4]. Inflamma-
tory mediators, such as interleukin 1 and 6, stimulate
megakaryocytic proliferation and cause thrombocytosis.
Thus, the platelet count may indicate inflammation. Studies
have shown a relationship between coronary artery diseases
and high platelet count [5e7]. In addition, lymphopenia is
an indicator of physiologic stress and poor general health
[8]. In this study, we aimed to reveal the relationship be-
tween CAS and platelet-to-lymphocyte ratio (PLR) values.
Materials and methods
Between January 2014 and May 2015, 140 patients who
underwent carotid angiography were included in this study.
An independent consultant neurologist evaluated all pa-
tients before the carotid intervention. Patients were
considered symptomatic if they had experienced a cerebral
infarct, transient ischemic attack, or amaurosis fugax
attributable to a lesion of the ipsilateral carotid artery
within the preceding 6 months. Clinical data such as hy-
pertension, previous stroke, diabetes mellitus, hyperlipid-
emia, current smoking status, coronary artery disease,
peripheral vascular disease/abdominal aortic aneurysm,
previous carotid stenting, previous carotid endarterectomy,
and chronic kidney disease were recorded. Demographic
data such as age and sex were also assessed. All patients
underwent carotid Doppler ultrasound, magnetic resonance
angiography, or computed tomography angiography of the
carotid arteries before the angiography.
Premedication, which consisted of aspirin (100 mg/d)
and clopidogrel (75 mg/d), was administered at least 2 days
before the procedure. Experienced interventional cardiol-
ogists performed all carotid diagnostic and therapeutic
interventional procedures. Vascular access was obtained
via a 6-Fr sheath in the common femoral artery. Carotid and
cerebral angiography was performed after an arch aorto-
gram (40 left anterior oblique) using a pigtail catheter. A
digital subtraction angiogram of the intracranial and
extracranial carotid circulation was obtained for at least
two projections.
The innominate and left subclavian arteries were
engaged using a 6-F Judkins Right (JR) 4 diagnostic cath-
eter. The JR catheter was advanced to the ascending aortic
root, torqued counter-clockwise for turning its tip superi-
orly, and then withdrawn into the vessel ostium. An angled
glide catheter was used in a similar manner. In elderly pa-
tients and patients with Type III arches, a Simmons catheter
(Cook, Bloomington, IN, USA) was used. We advanced the
Simmons catheter into the left subclavian artery first with a
0.038-inch guide wire. We then withdrew the guide wireand advanced the catheter, thereby achieving an angled
catheter tip in most patients. In some patients, we stran-
gled the tip of the Simmons catheters in the ascending
aorta. We repeatedly pulled back the catheter until se-
lective engaging of the innominate and left common carotid
arteries.
Standard anteroposterior and lateral projections were
used to delineate the carotid bifurcation. Additional pro-
jections were used in some patients. Cerebral angiography
was performed with standard anteroposterior and lateral
projections in all patients. Independent interventional
cardiologists retrospectively evaluated all angiographic
images.
The degree of stenosis was assessed according to the
North American Symptomatic Carotid Endarterectomy Trial
(NASCET) 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/
CNS /SAIP/SCA Guideline on the Management of Patients
with Extracranial Carotid and Vertebral Artery Disease
Criteria [5]. Internal carotid artery (ICA) stenosis of >50% in
symptomatic patients and ICA stenosis >80% in asymp-
tomatic patients were defined as critical for carotid
angiography.
Patients were divided into two groups. Group 1 had
critical ICA stenosis, whereas Group 2 had noncritical ICA
stenosis as assessed by carotid angiography.
Data from all patients were collected from hospital
medical records. Excluded from the study were patients
with any hematologic disease, recent arterial thrombotic
disease, cirrhosis, chronic pulmonary disease, chronic renal
disease, any diagnosed cancer, chronic inflammatory or
autoimmune diseases, active infection, or patients
receiving antibiotic treatment. After 12e14 hours of fast-
ing, venous blood samples were obtained from patients for
biochemical and hemogram analysis. Complete blood cell
counts and automated differential counts were determined
via an automated hematology analyzer (Abbott CELL-DYN
3700 System, Ramsey, Minnesota, 55303, USA), which pro-
vided total white blood count, platelet, neutrophil,
lymphocyte, monocyte, eosinophil, and basophils counts/
mL. The baseline PLR was calculated by dividing the abso-
lute platelet count by the absolute lymphocyte count. The
institutional ethics committee approved the study protocol.
Statistical analysis
Data analysis was performed using SPSS for Windows 17.0
(Statistical Package for Social Science; SPSS Inc., Chicago,
IL, USA). The mean differences of the continuous data were
measured by the t test and the median differences of the
categorical data were measured by the ManneWhitney U
and Fisher’s exact tests. A p value < 0.05 was accepted as
statistically significant. The Chi-square test was used to
compare differences between categorical variables.
Receiver operating characteristics curves (ROC) were con-
ducted, when appropriate.
Results
One hundred forty patients were included in the data
analysis. Patients were divided into two groups. Group 1
(nZ 64) included patients with critical CAS, whereas Group
Table 2 Hemogram parameters of patients with/without
critical carotid stenosis.
Critical carotid
stenosis group
(n Z 64)
Controls with no
critical stenosis
group (n Z 76)
p
WBC (K/mL) 8617  2370 7688  2095 0.417
Neu (K/mL) 4985  1942 4850  1851 0.993
Lymp (K/mL) 1882  637 2956  1404 <0.0001
Hb (g/dL) 13.0  1.7 13.3  1.6 0.544
PLT (K/mL) 272,750  87,235 234,910  58,952 0.012
MPV (fl) 7.6  1.1 7.9  1.1 0.713
PLR 162.5  84.7 94.9  60.3 <0.0001
The data are presented as mean  standard deviation.
Hb Z hemoglobin; Lymp Z lymphocyte; MPV Z mean platelet
volume; Neu Z neutrophil; PLR Z platelet-to-leukocyte ratio;
PLT Z platelet; WBC Z total white blood cell count.
Platelet counts and PLR levels are significantly higher and
lymphocyte levels are significantly lower in the critical carotid
stenosis group.
88 C. Varım et al.2 (n Z 76) included patients with noncritical CAS on angi-
ography. The groups were homogenous in demographic
characteristics and past medical history (Table 1). The
mean age of controls with noncritical stenosis was
68.5  9.8 years, and the mean age of the patients was
67.0  8.3 years. There were no significant differences in
sex and age between the two groups. Clinical and de-
mographic findings of groups are shown in Table 1.
The hemogram parameters of the controls with
noncritical stenosis and critical carotid stenosis group are
shown in Table 2. Total white blood cell count values were
8617  2370 K/mL in the critical carotid stenosis group and
7688  2095 K/mL in the noncritical carotid stenosis group
at p Z 0.417. Hemoglobin was 13.0  1.7 gr/dL in the
critical carotid stenosis group and 13.3  1.6 gr/dL in the
control group, respectively, at p Z 0.544. Neutrophil
counts were 4985  1942 K/mL in the critical carotid ste-
nosis group and 4850  1851 K/mL in the control group
at p Z 0.993. Lymphocyte counts were 1882  637 K/mL in
the critical carotid stenosis group and 2956  1404 K/mL
in the control group at p < 0.0001. Platelet counts were
272,750  87,235 K/mL in critical carotid stenosis group
and 234,910  58,952 K/mL in the control group at
pZ 0.012. The PLR was 162.5  84.7 in the critical carotid
stenosis group and 94.9  60.3 in the control group at
p < 0.0001.
The ROC analysis was performed to determine the PLR
cutoff value to predict total thrombosis of one of the ca-
rotid arteries. The ROC curve is shown in Figure 1. The PLR
was predictive at 117.1 with 89% sensitivity and 68% spec-
ificity (95%CI, 0.043e0.159; area under the curve,
0.101  0.03; Figure 1).
Age; the presence of diabetes mellitus, dyslipidemia,
and peripheral arterial disease; cigarette smoking; mean
platelet volume; and PLR were used as covariates for
multivariate analysis. In multivariable analysis, cigarette
smoking [hazard ratio (HR) Z 0.259; %95CI, 0.074e0.907;
p Z 0.035], and the PLR (HR Z 26.727; %95CI,
9.409e75.923; p < 0.001) have been shown to affect plaque
formation on carotid arteries.Table 1 Clinical and demographic findings of the two
groups.
Critical carotid
stenosis group
(n Z 64)
Controls with no
critical stenosis
group (n Z 76)
p
Age (mean  SD) 68.5  9.8 67.0  8.3 0.32
Sex (m, %) 42 (67.7) 38 (62.5) 0.202
HT 54 (84.3) 58 (76.3) 0.23
DM 16 (25.8) 18 (32.1) 0.413
HL 9 (11.8) 13 (20.3) 0.172
CAD 25 (35.9) 23 (32.9) 0.707
Cigarette 13 (19.1) 19 (29.7) 0.078
PAD 7 (9.7) 6 (9.4) 0.97
The data are presented as mean (%) unless otherwise indicated.
CAD Z coronary artery disease; DM Z diabetes mellitus;
HL Z hyperlipidemia; HT Z hypertension; m Z male;
PAD Z peripheral artery disease; SD Z standard deviation.Discussion
The PLR values were higher in patients with critical CAS in
our study. A preprocedural PLR of >117.1 had 89% sensi-
tivity and 68% specificity for predicting critical stenosis in
the carotid artery. A review of the literature shows that our
study is the first showing a relationship between the PLR
and CAS.
Carotid artery stenosis is a progressive disease of
atherosclerosis [5]. Atherosclerosis-related mortality re-
mains the most common cause of death around the world.
Atherosclerotic plaque is similar to inflammation in many
respects. The role of inflammation has been detected at
every stage of the atherosclerotic process [9]. At the his-
tological level, immunoglobulins, T lymphocytes, plasma
cells, and the presence of antigen-antibody complex in the
atheroma plaque suggest the importance of inflammation inFigure 1. The ROC curve for PLR to predict critical stenosis
in a carotid artery. The PLR is predictive at 117.1 with 89%
sensitivity and 68% specificity (95% CI, 0.043e0.159; AUC,
0.101  0.03). AUC Z area under the curve; CI Z confidence
interval; PLR Z platelet-to-lymphocyte ratio; ROC Z receiver
operating characteristic curve.
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flammatory conditions lead to megakaryocytic proliferation
and thrombocytosis [11].
Platelets are 2e4 mm in diameter. They are small, non-
nucleated, oval or round discoid blood cells. Platelets have
an important role in the initiation of atherosclerotic le-
sions. Mediators released from platelets such as throm-
boxane A2, adenosine diphosphate, serotonin, platelet
activating factor, and platelet-derived growth factor in-
crease platelet activation and aggregation. They also
stimulate the growth of vascular smooth muscle and
chemotaxis for inflammatory cells and fibroblasts [12,13].
Cardiovascular events are primarily associated with a
high platelet count [14e16]. There is a relationship be-
tween mortality and high platelet count in patients with
acute coronary syndrome [16]. High baseline platelet
counts demonstrate the instability of plaque and are asso-
ciated with stent thrombosis on follow-up [17].
Lymphocytes are blood cells responsible for cellular and
humoral immunity in the body. Recent studies have shown
that lymphocyte counts decrease in acute coronary syn-
drome and congestive heart failure. This decrease is
probably because of increase in the cortisol secondary to
stress [18,19]. A low lymphocyte count is associated with a
worse prognosis [20].
The PLR has come into use recently as an indicator of the
balance between inflammation and thrombosis. It may be
more advantageous than platelet or lymphocyte counts
alone. High PLR values are associated with cardiovascular
diseases and adverse outcomes [18e21]. Oylumlu et al
found that high PLR levels before primary percutaneous
coronary intervention with stent placement in patients
presenting with acute ST segment elevation myocardial
infarction may predict the development of future stent
thrombosis [20]. A basal PLR of >150 showed 63% sensitivity
and 70% specificity in predicting stent thrombosis [20]. An
association between high PLR values and increased long-
term mortality in patients with non-ST segment elevation
myocardial infarctions was found in a previous study [18]. In
another study, high PLR levels were a significant predictor
for nondipper hypertension [21]. Gary et al [22] demon-
strated that high PLR levels were associated with critical
peripheral ischemia. The relationship between a high PLR
and slow coronary flow phenomenon has been demon-
strated by Oylumlu et al [23].
In our study, we were able to demonstrate that high PLR
values are related to critical stenosis in the carotid artery.
ThePLRmaybeapredictormarker for evaluating the severity
of CAS in patients who have undergone carotid angiography.
In conclusion, analysis of basal PLR values is a cheap and
easy method that may be used in patients for the prediction
of critical CAS. We reached this conclusion using a retro-
spective study. Larger prospective and multicenter studies
must be performed to explain the relationship between the
PLR and CAS.References
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